We first analyzed GATA2 chromatin immunoprecipitation sequencing (ChIP-seq) profiles of LNCaP cancer cell line published previously (33) to estimate the distance between each GATA2 binding site and its potential target gene. The gene discussed is GATA2; the disease is cancer.